Media Highlights and Announcements
ausbizFebruary 08, 2022
This Aussie MedTech is fast going global
John Barrington AM talks to ausbiz about the company’s strategy across the US, UK and Europe, and shares insights into the recent December quarter update.
Proactive InvestorsFebruary 05, 2022
Artrya talks through its plan to bring its AI coronary heart disease diagnostic to the US
John Barrington AM talks to Proactive Investor about the company’s appointment of Dr. Jacque Sokolov as Chair of Artrya’s Clinical Advisory Board.
Artrya Limited (ASX: AYA, Artrya or the Company) is today announcing the appointment of renowned healthcare executive Dr. Jacque J. Sokolov as Chair of Artrya’s Clinical Advisory Board.
Bio WorldNovember 30, 2021
Artrya lists on ASX in AU$40M IPO to advance coronary artery disease AI software
Medtech newcomer Artrya Ltd. listed on the Australian Securities Exchange (ASX) in an AU$40 million (US$28.6 million) initial public offering.
The Motley FoolNovember 29, 2021
New artificial intelligence ASX share rockets 13% on debut
Move over Appen, the new AI player in town went gangbusters on its first day as a public company.
November 26, 2021
Artrya gets to the heart of AI with ASX listing, $40 million IPO
Fresh from its ASX debut, AYA’s mission is simple: it’s out to more accurately and less invasively detect signs of heart disease with the power of artificial intelligence (AI).
Business NewsNovember 26, 2021
Artrya rises on ASX debut
Local medtech Artya has listed on the stock exchange, having earlier raised $40 million through an IPO to help commercialise its cardiac imaging software.
The Market HeraldNovember 26, 2021
Cardiac imaging software company Artrya (ASX:AYA) up on public debut
Artrya (AYA), an artificial intelligence medical technology business, has started trading on the ASX after the successful completion of its initial public offering (IPO).
StockheadNovember 26, 2021
How did this week’s five IPOs perform?
The medical technology company listed today after raising $40 million at $1.35. Its share price is up ~13% to $1.52.
November 26, 2021